Free Trial
NASDAQ:CME

CME Group (CME) Stock Price, News & Analysis

CME Group logo
$276.07 +3.71 (+1.36%)
As of 03:46 PM Eastern

About CME Group Stock (NASDAQ:CME)

Key Stats

Today's Range
$270.24
$276.40
50-Day Range
$247.75
$272.36
52-Week Range
$190.70
$278.08
Volume
1.07 million shs
Average Volume
2.16 million shs
Market Capitalization
$99.48 billion
P/E Ratio
28.55
Dividend Yield
1.81%
Price Target
$256.80
Consensus Rating
Hold

Company Overview

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.

CME Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
86th Percentile Overall Score

CME MarketRank™: 

CME Group scored higher than 86% of companies evaluated by MarketBeat, and ranked 385th out of 949 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CME Group has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 5 buy ratings, 7 hold ratings, and 3 sell ratings.

  • Amount of Analyst Coverage

    CME Group has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about CME Group's stock forecast and price target.
  • Earnings Growth

    Earnings for CME Group are expected to grow by 4.77% in the coming year, from $10.49 to $10.99 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CME Group is 28.56, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.72.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CME Group is 28.56, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 21.95.

  • Price to Earnings Growth Ratio

    CME Group has a PEG Ratio of 6.76. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    CME Group has a P/B Ratio of 3.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.38% of the float of CME Group has been sold short.
  • Short Interest Ratio / Days to Cover

    CME Group has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CME Group has recently decreased by 12.83%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    CME Group pays a meaningful dividend of 1.88%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    CME Group does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of CME Group is 50.30%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, CME Group will have a dividend payout ratio of 45.50% next year. This indicates that CME Group will be able to sustain or increase its dividend.

  • Read more about CME Group's dividend.
  • Percentage of Shares Shorted

    1.38% of the float of CME Group has been sold short.
  • Short Interest Ratio / Days to Cover

    CME Group has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in CME Group has recently decreased by 12.83%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    CME Group has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Finance companies.
  • News Coverage This Week

    MarketBeat has tracked 56 news articles for CME Group this week, compared to 24 articles on an average week.
  • Search Interest

    17 people have searched for CME on MarketBeat in the last 30 days. This is an increase of 89% compared to the previous 30 days.
  • MarketBeat Follows

    16 people have added CME Group to their MarketBeat watchlist in the last 30 days. This is an increase of 23% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CME Group insiders have sold 234,736.43% more of their company's stock than they have bought. Specifically, they have bought $3,151.00 in company stock and sold $7,399,696.00 in company stock.

  • Percentage Held by Insiders

    Only 0.30% of the stock of CME Group is held by insiders.

  • Percentage Held by Institutions

    87.75% of the stock of CME Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about CME Group's insider trading history.
Receive CME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter.

CME Stock News Headlines

Photo of the word Upgrade on a blue background, a finger pressing a button next to it
Morgan Stanley: 3 Financial Stocks That Will Thrive in Volatility
Morgan Stanley upgrades CBOE, CME Group, and MarketAxess (MKTX), forecasting growth as investors hedge volatility and recession risks.
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.
CME Group: Expect Generous Dividends This Year
CME Group (NASDAQ:CME) Price Target Raised to $305.00 at UBS Group
3 Stocks to Buy Before the May 7 Catalyst
See More Headlines

CME Stock Analysis - Frequently Asked Questions

CME Group's stock was trading at $232.23 at the beginning of 2025. Since then, CME stock has increased by 18.9% and is now trading at $276.20.
View the best growth stocks for 2025 here
.

CME Group Inc. (NASDAQ:CME) released its earnings results on Wednesday, April, 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.19. The business's quarterly revenue was up 10.4% compared to the same quarter last year.
Read the conference call transcript
.

CME Group's board approved a share buyback plan on Thursday, December 5th 2024, which allows the company to buy back $3,000,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 3.4% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's board believes its shares are undervalued.

CME Group's top institutional investors include Bank of New York Mellon Corp (1.71%), Vontobel Holding Ltd. (0.79%), GAMMA Investing LLC (0.52%) and Sarasin & Partners LLP (0.49%). Insiders that own company stock include Terrence A Duffy, Bryan T Durkin, Larry G Gerdes, Julie Holzrichter, Sunil Cutinho, Hilda Harris Piell, Martin J Gepsman, Julie Winkler, Howard J Siegel, Elizabeth A Cook, Terry L Savage, Terry L Savage, Daniel R Glickman, Lynne Fitzpatrick, Ken Vroman, Timothy S Bitsberger, Derek Sammann, Suzanne Sprague, Timothy Francis Mccourt, Charles P Carey, Dennis Suskind and William R Shepard.
View institutional ownership trends
.

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CME Group investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST).

Company Calendar

Record date for 3/26 Dividend
3/07/2025
Ex-Dividend for 3/26 Dividend
3/07/2025
Dividend Payable
3/26/2025
Last Earnings
4/23/2025
Today
4/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Finance
Industry
Security & commodity brokers, dealers, exchanges & services
Sub-Industry
Specialized Finance
Current Symbol
NASDAQ:CME
Employees
3,460
Year Founded
1848

Price Target and Rating

Average Stock Price Target
$256.80
High Stock Price Target
$305.00
Low Stock Price Target
$198.00
Potential Upside/Downside
-5.7%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
16 Analysts

Profitability

Trailing P/E Ratio
28.17
Forward P/E Ratio
25.96
P/E Growth
6.76
Net Income
$3.53 billion
Pretax Margin
74.08%

Debt

Sales & Book Value

Annual Sales
$6.28 billion
Cash Flow
$12.41 per share
Price / Cash Flow
21.95
Book Value
$73.50 per share
Price / Book
3.71

Miscellaneous

Free Float
359,281,000
Market Cap
$98.15 billion
Optionable
Optionable
Beta
0.43

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:CME) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners